FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.1444.3.210
Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113883.3.1444.3.210 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.210/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.210 |
Version | 20230707 |
Status | active |
Date | 2023-07-07T01:01:08-04:00 |
Name | MultigenePanel |
Title | Multigene Panel |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for the procedure of multigene panel.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for multigene panel that includes testing for BRCA1 and BRCA2.),(Exclusion Criteria: No exclusions.) |
Resources that use this resource
Resources that this resource uses
CodeSystem |
cpt | Current Procedural Terminology (CPT®) |
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.3.1444.3.210",
"meta": {
"versionId": "7",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "American Society of Clinical Oncology Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-08-01"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2023-07-07"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.210",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.3.1444.3.210"
}
],
"version": "20230707",
"name": "MultigenePanel",
"title": "Multigene Panel",
"status": "active",
"date": "2023-07-07T01:01:08-04:00",
"publisher": "American Society of Clinical Oncology Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for the procedure of multigene panel.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for multigene panel that includes testing for BRCA1 and BRCA2.),(Exclusion Criteria: No exclusions.)",
"compose": {
"include": [
{
"system": "http://www.ama-assn.org/go/cpt",
"concept": [
{
"code": "81432",
"display": "Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer); genomic sequence analysis panel, must include sequencing of at least 10 genes, always including BRCA1, BRCA2, CDH1, MLH1, MSH2, MSH6, PALB2, PTEN, STK11, and TP53"
},
{
"code": "81433",
"display": "Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer); duplication/deletion analysis panel, must include analyses for BRCA1, BRCA2, MLH1, MSH2, and STK11"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:942743ee-0e06-4b5a-9d36-4828faf981e2",
"timestamp": "2025-05-23T21:54:53-04:00",
"total": 1,
"contains": [
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "81432",
"display": "Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer, hereditary pancreatic cancer, hereditary prostate cancer), genomic sequence analysis panel, 5 or more genes, interrogation for sequence variants and copy number variants"
}
]
}
}